Tonix Pharmaceuticals stock sinks on pricing $7M public offering_老虎社区_美港股上老虎

Tonix Pharmaceuticals stock sinks on pricing $7M public offering

seekingalpha2023-07-28

Tonix Pharmaceuticals (NASDAQ:TNXP) to sell 7M shares of its common stock and warrants to purchase up to 7M shares in a public offering at a combined offering price of $1.00 per share. The gross ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

黑色幽默nio
·2023-07-28
垃圾中的战斗机
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2354746681?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2023-07-28 17:49","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2354746681","market":"us","top_or_hot":-1,"title":"Tonix Pharmaceuticals stock sinks on pricing $7M public offering","media":"seekingalpha","content":"<div>\n<p>Tonix Pharmaceuticals (NASDAQ:TNXP) to sell 7M shares of its common stock and warrants to purchase up to 7M shares in a public offering at a combined offering price of $1.00 per share. The gross ...</p>\n\n<a href=\"https://seekingalpha.com/news/3992695-tonix-pharmaceuticals-stock-sinks-on-pricing-7m-public-offering\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tonix Pharmaceuticals stock sinks on pricing $7M public offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTonix Pharmaceuticals stock sinks on pricing $7M public offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-28 17:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3992695-tonix-pharmaceuticals-stock-sinks-on-pricing-7m-public-offering><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tonix Pharmaceuticals (NASDAQ:TNXP) to sell 7M shares of its common stock and warrants to purchase up to 7M shares in a public offering at a combined offering price of $1.00 per share. The gross ...</p>\n\n<a href=\"https://seekingalpha.com/news/3992695-tonix-pharmaceuticals-stock-sinks-on-pricing-7m-public-offering\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNXP","symbol_name":"Tonix Pharmaceuticals Holding Co","start_time":0,"source_url":"https://seekingalpha.com/news/3992695-tonix-pharmaceuticals-stock-sinks-on-pricing-7m-public-offering","article_id":"2354746681","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2354746681","pubTimestamp":1690537786,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Tonix Pharmaceuticals  to sell 7M shares of its common stock and warrants to purchase up to 7M shares in a public offering at a combined offering price of $1.00 per share. The gross proceeds of the offering will be approximately $7 million.   The warrants will be exercisable starting from the issuance date and expire five years after the issuance date.  The offering is expected to close on or about August 1, 2023. Net proceeds will be used for working capital, general corporate purposes, manufacturing and research facilities, and the acquisition or licensing of approved products and in-development products. Shares down 39% during premarket hours.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNXP":"Tonix Pharmaceuticals Holding Co","BK4139":"生物科技","BK4583":"猴痘概念"},"translate_title":"Tonix Pharmaceuticals股票在定价为700万美元的公开发行中下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNXP":1},"content_text":"Tonix Pharmaceuticals (NASDAQ:TNXP) to sell 7M shares of its common stock and warrants to purchase up to 7M shares in a public offering at a combined offering price of $1.00 per share. The gross proceeds of the offering will be approximately $7 million.   The warrants will be exercisable starting from the issuance date and expire five years after the issuance date.  The offering is expected to close on or about August 1, 2023. Net proceeds will be used for working capital, general corporate purposes, manufacturing and research facilities, and the acquisition or licensing of approved products and in-development products. Shares down 39% during premarket hours.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":202860138979520,"gmtCreate":1690556629011,"gmtModify":1690556879871,"author":{"id":"3557575629963896","authorId":"3557575629963896","name":"黑色幽默nio","avatar":"https://static.tigerbbs.com/1e0a1166faa0ed5410c5d3b5c93de803","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"垃圾中的战斗机","listText":"垃圾中的战斗机","text":"垃圾中的战斗机","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/202860138979520","repostId":2354746681,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}